Neurology Specific Literature Search   
 
[home][thesaurus]
    
Click Here to return To Results

 

The Catechol-O-Methyltransferase (COMT) Inhibitor Entacapone Enhances the Pharmacokinetic and Clinical Response to Sinemet CR in Parkinson's Disease
JNNP 68:589-594, Piccinni,P.,et al, 2000
See this aricle in Pubmed

Article Abstract
These data confirm the clinical efficacy of entacapone-standard Sinemet combination. They also indicate that adding entacapone to controlled release levodopa preparations might provide a useful treatment option in patients with Parkinson's disease with motor fluctuations. A double blind clinical trial with a chronically administered entacapone Sinemet CR combination is, however, required to verify this viewpoint.
 
Related Tags
(click to filter results - removes previous filter)

catechol-o-methyltransferase inhibitor
entacapone
L-dopa
L-dopa,controlled release
Parkinson disease
Parkinson disease,treatment of
sinemet
treatment of neurologic disorder

Click Here to return To Results